montelukast  - Drug Details
📊 Estimates montelukast  Dialyzability By Different_Modalities

montelukast 

Complete Drug Information

Drug Name
montelukast 
Trade Names
Singulair
Pregnancy Category
AU: B1
Bioavailability
63–73%
Routes of Administration
Oral
Protein Binding
99%%
Metabolism
Liver (CYP2C8-major, CYP3A4 and CYP2C9-minor)
Elimination
2.7–5.5 hours
Excretion
Bile duct
Formula
C35H36ClNO3S
Molar Mass
586.19
Melting Point
145 to 148 °C
Drug Class
Leukotriene receptor antagonist
Volume of Distribution
8 L/kg

🤰 Pregnancy Category Information

Category: AU: B1

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies have not shown evidence of an increased occurrence of fetal damage.